The Centers for Disease Control and Prevention (CDC) has ordered $2.7 million in personal protective equipment (PPE) to increase Strategic National Stockpile (SNS) supplies to assist U.S. hospitals caring for Ebola patients. Products are being configured into 50 kits that can be rapidly delivered to hospitals. Each kit can provide the PPE needed by clinical teams to manage the care of one Ebola patient for up to five days.
CDC personnel are assembling product from the Strategic National Stockpile into an individual personal protective equipment kits, each of which can be used to care for one Ebola patient for up to five days. Photo courtesy of the CDC.
The Centers for Disease Control and Prevention (CDC) has ordered $2.7 million in personal protective equipment (PPE) to increase Strategic National Stockpile (SNS) supplies to assist U.S. hospitals caring for Ebola patients. Products are being configured into 50 kits that can be rapidly delivered to hospitals. Each kit can provide the PPE needed by clinical teams to manage the care of one Ebola patient for up to five days.
Purchases are based on PPE guidance for caring for Ebola patients that was issued by CDC on Oct. 20, 2014. As product is delivered to SNS facilities, it is assembled into kits by SNS personnel. The kits can be rapidly delivered from the SNS as requested to those hospitals that receive suspected or confirmed Ebola cases but may need additional PPE supplies that otherwise are not immediately available.
Although the number of kits is limited, they will help address short-term PPE needs. Purchases include impermeable gowns, coveralls, and aprons; boot covers; gloves; face shields and hoods; N95 respirators; powered-air purifying respirator systems and ancillaries; and disinfecting wipes.
Since the issuance of the CDC guidance, there has been a sudden increase in demand for PPE. Across the United States, availability for these products varies by product type and model, requested quantity, manufacturer, distributor, and geographic region.
“We are making certain to not disrupt the orders submitted by states and hospitals, but we are building our stocks so that we can assist when needed. Some of these products are not normally used by hospitals for regular patient care,” says Greg Burel, director of CDC’s Division of Strategic National Stockpile.
There are alternatives that can be used in the event certain products are unavailable, and those alternatives are included in CDC’s guidance. CDC continues to coordinate with manufacturers, distributors and health care facilities to monitor the availability of products in the supply chain. No products are being held by manufacturers or distributors specifically for SNS orders, and SNS orders are not being prioritized ahead of orders placed by hospitals.
Hospitals should coordinate with their state public health departments if there is a need to request PPE supplies from CDC to care for an Ebola patient. The state health department will follow the established protocol for submitting this request to CDC. The latest CDC PPE guidance is available at http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html.
The Strategic National Stockpile is receiving new orders of personal protective equipment to assemble kits that can be rapidly deployed to a U.S. hospital that receives an Ebola patient. Each kit has enough equipment to care for one Ebola patient for up to five days until other supplies can be located. Photo courtesy of the CDC.
Source: CDC
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.